AVR anteris technologies global corp.

AHZ is 2 companies -why not split into 2?, page-9

  1. 3,997 Posts.
    lightbulb Created with Sketch. 687
    Bells, you don't let the vax side of the business go: you keep it. It's just that you would own AHZ1 and AHZ2, rather than AHZ, the conglomerate.

    The market has enough trouble valuing a medtech or biotech company as it is, without having to wrestle with 5+ very different subsidiaries, all at different stages of development.

    It's a very weird and unnatural mix... I don't even know how it happened! Maybe some long-termer could tell me.

    Did one of the bosses from long back say, "I have always had this urge to cure cancer"... Or "I just met a really clever guy who reckons he can come up with a vaccine for Herpes. I think we should give him some of our latest cap raise".. or something equally weird!!!!

    Or was it the other way around: "Let's buy cardiocel as a quick and easy way to profits to self-fund our biotech aspirations?"
    Last edited by hotcongo: 17/03/17
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$4.91
Change
-0.270(5.21%)
Mkt cap ! $76.12M
Open High Low Value Volume
$5.15 $5.15 $4.88 $58.96K 11.74K

Buyers (Bids)

No. Vol. Price($)
1 497 $4.91
 

Sellers (Offers)

Price($) Vol. No.
$4.95 5000 1
View Market Depth
Last trade - 16.10pm 21/07/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.